September 26, 2018
A New Jersey federal judge Wednesday dismissed PricewaterhouseCoopers LLP from a price-gouging suit from Valeant Pharmaceuticals shareholders, finding that the investors failed to allege a motive to commit fraud.
April 13, 2018
A proposed class of Valeant Pharmaceuticals shareholders told a New Jersey federal judge Thursday that all of the claims against the company, its executives and several banks over a price-gouging scheme that cost shareholders $80 billion were adequately pled, contrary to a volley of partial dismissal bids pushed by the defendants.
January 02, 2018
Valeant Pharmaceuticals International Inc.'s alleged price-gouging scheme cost shareholders more than $80 billion once the scheme came to light, investors said in a suit filed in New Jersey district court Tuesday.